BTC$60,654.00-0.59%
ETH$1,559.10-1.26%
USDT$0.9996-0.01%
BNB$573.34+0.04%
USDC$0.9997+0.01%
XRP$1.09-1.35%
SOL$61.91-3.12%
TRX$0.3237+0.86%
FIGR_HELOC$1.03+0.46%
DOGE$0.0814-0.42%
HYPE$56.44-5.27%
USDS$0.9997-0.02%
LEO$9.44-1.44%
RAIN$0.0128-1.63%
XLM$0.2116+5.14%
CC$0.1627+9.72%
BTC$60,654.00-0.59%
ETH$1,559.10-1.26%
USDT$0.9996-0.01%
BNB$573.34+0.04%
USDC$0.9997+0.01%
XRP$1.09-1.35%
SOL$61.91-3.12%
TRX$0.3237+0.86%
FIGR_HELOC$1.03+0.46%
DOGE$0.0814-0.42%
HYPE$56.44-5.27%
USDS$0.9997-0.02%
LEO$9.44-1.44%
RAIN$0.0128-1.63%
XLM$0.2116+5.14%
CC$0.1627+9.72%
UnitedHealth Group shares surged over 12% in premarket trading after Warren Buffett's Berkshire Hathaway disclosed a new $1.57 billion stake.
Intel shares gained in premarket trading after reports emerged that the Trump administration is considering taking a stake in the chipmaker.
Even amid the institutional hostility of the Biden era, Ethereum kept building its ecosystem, now dominating DeFi and stablecoin markets with analysts forecasting new all-time highs.
Lower ad spend from a key DSP partner sent PubMatic’s stock reeling, even as the company doubles down on CTV and AI-driven monetization.
Many of Cathie Wood’s bets have turned sour. Is The Trade Desk another one in the making?
Delta Air Lines stock jumped as the DOJ backed revoking antitrust immunity for its Aeroméxico partnership.
Tesla stock gains 3.87% following robotaxi permit approval in Texas and UK energy license application.
C3.ai shares crashed over 32% in premarket trading after reporting preliminary Q1 revenue of $70.2-$70.4 million, falling 33% below guidance.
Nvidia and AMD shares are declining in premarket trading while Intel gains, driven by significant news.
Duolingo shows that specialized AI-powered platforms are more than capable of capturing subscribers, despite the availability of general-purpose LLMs.
SoundHound AI delivered record Q2 2025 results with 217% revenue growth to $42.7 million, beating estimates by nearly $10 million.
Duolingo's stock surged over 30% following strong Q2 earnings, driven by AI-powered user growth and raised guidance.
Eli Lilly's stock crashed over 14% despite strong Q2 earnings, as disappointing weight-loss pill trial results overshadowed 38% revenue growth and raised guidance.